The Recognition, Assessment and Management of Dementing Disorders: Conclusions from the Canadian Consensus Conference on Dementia (Q60712642)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

C Patterson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Gauthier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Bergman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Cohen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J W Feightner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Feldman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Grek

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

28 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

S1

0 references

page(s)

S3-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology's practice parameters

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Do general practitioners miss dementia in elderly patients?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Guidelines on drug treatments for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Delirium in the elderly patient

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

A metaanalysis of controlled trials of neuroleptic treatment in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Antioxidants and Atherosclerotic Heart Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Diagnosis of vascular dementia: Consortium of Canadian Centres for Clinical Cognitive Research concensus statement.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Dementia: diagnosis and evaluation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Instruments for screening for depression and dementia in a long-term care facility.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Informant ratings of cognitive decline of elderly people: relationship to longitudinal change on cognitive tests.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

15-year longitudinal study of blood pressure and dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Dementia in elderly outpatients: a prospective study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Predicting who will develop dementia in a cohort of Canadian seniors.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Diagnosing dementia: a comparison between a monodisciplinary and a multidisciplinary approach.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Do long tests yield a more accurate diagnosis of dementia than short tests? A comparison of 5 neuropsychological tests

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Measurement of functional activities in older adults in the community.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Should patients with Alzheimer's disease be told their diagnosis?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Mild cognitive impairment: conceptual basis and current nosological status.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Validation of cognitive and functional assessment instruments in vascular dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Practice parameter for diagnosis and evaluation of dementia. (summary statement) Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Do cognitive complaints either predict future cognitive decline or reflect past cognitive decline? A longitudinal study of an elderly community sample.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Effect of education on the mini-mental state examination as a screening test for dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Stroke prevention in nonvalvular atrial fibrillation: A review of prospective randomized trials

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

The Mini-Mental State Examination: A Comprehensive Review

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Dementia in old age: an anthropological perspective

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Driving and Alzheimer's disease: the risk of crashes

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Subjective memory complaints and personality traits in normal elderly subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Vitamin supplements and cancer risk: the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Earlier onset of Alzheimer's disease in men with Down syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

The association between head trauma and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Vitamin/mineral supplementation and cancer risk: international chemoprevention trials

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Recent developments in the management of psychosis.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Psychiatric phenomena in Alzheimer's disease. III: Disorders of mood

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Depression in dementia of the Alzheimer type and in multi-infarct dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Evaluation of dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Antipsychotic agents in patients with dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Reliability of the Washington University Road Test. A performance-based assessment for drivers with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

https://api.crossref.org/works/10.1017%2FS0317167100001165

1 reference

7 January 2021

The effect of different diagnostic criteria on the prevalence of dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Behavioral disturbance in dementia of the Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Population-based norms for the Mini-Mental State Examination by age and educational level

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

A randomized, placebo-controlled trial of thiothixene in agitated, demented nursing home patients'

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Presence and treatment of vascular risk factors in patients with vascular cognitive impairment.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

The relationship between white matter low attenuation on brain CT and vascular risk factors: a memory clinic study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Screening for cognitive impairment in general practice: toward a consensus.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Rivastigmine for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Do cultural differences affect Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

Aggressive behavior in hospitalized psychogeriatric patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001165

7 January 2021

10.1017/S0317167100001165

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11237309%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference